Amylyx Pharmaceuticals, Inc. (AMLX)
38.14
-0.52
(-1.35%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals PE Ratio
PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio Data
| Date | Value |
|---|---|
| March 28, 2024 | 4.029 |
| March 27, 2024 | 4.086 |
| March 26, 2024 | 3.887 |
| March 25, 2024 | 3.844 |
| March 22, 2024 | 3.887 |
| March 21, 2024 | 4.072 |
| March 20, 2024 | 4.213 |
| March 19, 2024 | 4.157 |
| March 18, 2024 | 4.057 |
| March 15, 2024 | 4.596 |
| March 14, 2024 | 4.497 |
| March 13, 2024 | 4.880 |
| March 12, 2024 | 4.880 |
| March 11, 2024 | 5.391 |
| March 08, 2024 | 4.767 |
| March 07, 2024 | 26.91 |
| March 06, 2024 | 27.03 |
| March 05, 2024 | 26.74 |
| March 04, 2024 | 27.15 |
| March 01, 2024 | 26.54 |
| February 29, 2024 | 26.74 |
| February 28, 2024 | 27.76 |
| February 27, 2024 | 26.95 |
| February 26, 2024 | 24.91 |
| February 23, 2024 | 25.04 |
| Date | Value |
|---|---|
| February 22, 2024 | 26.30 |
| February 21, 2024 | 21.72 |
| February 20, 2024 | 21.15 |
| February 16, 2024 | 22.53 |
| February 15, 2024 | 21.82 |
| February 14, 2024 | 21.38 |
| February 13, 2024 | 21.22 |
| February 12, 2024 | 23.05 |
| February 09, 2024 | 22.90 |
| February 08, 2024 | 21.93 |
| February 07, 2024 | 21.45 |
| February 06, 2024 | 22.07 |
| February 05, 2024 | 21.71 |
| February 02, 2024 | 22.39 |
| February 01, 2024 | 23.51 |
| January 31, 2024 | 22.70 |
| January 30, 2024 | 22.16 |
| January 29, 2024 | 22.40 |
| January 26, 2024 | 21.82 |
| January 25, 2024 | 21.80 |
| January 24, 2024 | 20.39 |
| January 23, 2024 | 20.73 |
| January 22, 2024 | 20.84 |
| January 19, 2024 | 21.29 |
| January 18, 2024 | 21.11 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Pfizer Inc. | 37.05 |
| Eli Lilly & Co. | 42.39 |
| Merck & Co., Inc. | 120.47 |
| EyePoint, Inc. | -- |
| Bristol Myers Squibb Co. | 14.83 |
PE Ratio Related Metrics
| Price to Book Value | 17.76 |
| Price | 38.14 |
| Earnings Yield | -3.76% |
| Market Cap | 4.248B |